HIV-AIDS | Microbicide Trials Network

Tennessee replaced its federal HIV funding with state money. Public health experts say the change is causing damage. - WPLN

Mon, 10/21/2024 - 15:12

Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks - AOL

Mon, 10/21/2024 - 14:46

Long-Acting Injectable HIV Therapy: Addressing Adherence Challenges - Contagionlive.com

Mon, 10/21/2024 - 14:25

Meet our Health Hero of the Year, Armonté Butler - Plus

Mon, 10/21/2024 - 13:54

Pembrolizumab aids survival with high-risk endometrial cancer - Medical Xpress

Mon, 10/21/2024 - 13:50

Multiple Paths to HIV Prevention: The Power of Choice - Metro Weekly

Mon, 10/21/2024 - 13:03

Multiple Paths to HIV Prevention: The Power of Choice - Metro Weekly

Mon, 10/21/2024 - 12:44

Protect Yourself from the Flu: Important Info for People With HIV - HIV.gov

Mon, 10/21/2024 - 12:34

Making history while reporting it: a legendary journalist’s crusade against AIDS - LGBTQ Nation

Mon, 10/21/2024 - 12:00

Analyzing Knowledge Status and HIV Linkage to Care: Insights From America’s HIV Epidemic Analysis Dashboard (AHEAD) National Database - Cureus

Mon, 10/21/2024 - 11:47

Success of long-lasting HIV drug hinges on pricing - SciDev.Net

Mon, 10/21/2024 - 11:40

40 Years in Global Health – an Interview With Dr. John Bartlett - Duke University

Mon, 10/21/2024 - 11:30

Lil’ Kim Sets Off AIDS Walk Atlanta With Show-Stopping Set & Gary With Da Tea Drops Gems On Available Resources [Exclusive] - Bossip

Mon, 10/21/2024 - 11:21

Program Assistant, Re-Envisioning Excellence and Accessibility in Clinic-based HIV Services (REACH 95) project - Kyiv Post

Mon, 10/21/2024 - 08:48

Groups With Highest Unmet PrEP Needs Emerge in Analysis - Medscape

Mon, 10/21/2024 - 06:44

Torque teno virus: a potential marker of immune reconstitution in youths with vertically acquired HIV - Nature.com

Mon, 10/21/2024 - 05:48

Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks, setting stage for pivotal program - Fierce Biotech

Mon, 10/21/2024 - 05:06

Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks, setting stage for pivotal program - Fierce Biotech

Mon, 10/21/2024 - 05:06

Aidsfonds warning as more young men are diagnosed with HIV - DutchNews.nl

Mon, 10/21/2024 - 03:36

UNAIDS calls for global solidarity to strengthen Madagascar’s HIV response to end AIDS as a public health threat - UNAIDS

Mon, 10/21/2024 - 03:00

HIV infections no longer falling; On the rise among young men - NL Times

Mon, 10/21/2024 - 02:08

Successful Biological Treatment of a Patient With Psoriasis and HIV - Cureus

Mon, 10/21/2024 - 01:37

New Strategies to Extend the HIV Treatment Cascade for CVD Prevention - Infectious Disease Special Edition

Mon, 10/21/2024 - 00:18

Sweden exceeds UNAIDS HIV goals but faces new challenges - News-Medical.Net

Sun, 10/20/2024 - 23:41

Fighting the stigma: A Detroit HIV survivor shares his story to help others with virus - Detroit News

Sun, 10/20/2024 - 23:03

A Retrospective Cross-Sectional Study of Clinical Profile of HIV Patients at a Tertiary Care Hospital in Western Part of Maharashtra - Cureus

Sun, 10/20/2024 - 21:18

Europe rights court rules Italy did not violate convention by keeping man with AIDS in prison during COVID - JURIST

Sun, 10/20/2024 - 20:57

Cost-effectiveness of screening and treating alcohol use and depression among people living with HIV in Zimbabwe: a mathematical modeling study - BMC Medicine

Sun, 10/20/2024 - 20:34

A time to look back, to look ahead, to love, to hope — AIDS Walk Philly a reminder of the work yet to be done - KYW

Sun, 10/20/2024 - 15:52

Predictors of CD4 cell count progression over time among adolescents and young adults transitioning to adult-oriented HIV care in Southern Ethiopia from 2017 to 2021: a retrospective cohort study - BMC Public Health

Sun, 10/20/2024 - 05:30